{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:56:12Z","timestamp":1769828172433,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017242","name":"NIFDC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biosafety and Health"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bsheal.2024.09.002","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:53:40Z","timestamp":1725378820000},"page":"279-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population"],"prefix":"10.1016","volume":"6","author":[{"given":"Qi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyong","family":"Jian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4246-8889","authenticated-orcid":false,"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bsheal.2024.09.002_b0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-0716-2635-1_17","article-title":"Roles of sialyl glycans in HCoV-OC43, HCoV-HKU1, MERS-CoV and SARS-CoV-2 infections","volume":"2556","author":"Sriwilaijaroen","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"12","key":"10.1016\/j.bsheal.2024.09.002_b0010","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.bsheal.2024.09.002_b0015","doi-asserted-by":"crossref","first-page":"e2282","DOI":"10.1002\/rmv.2282","article-title":"An overview on the seven pathogenic human coronaviruses","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bsheal.2024.09.002_b0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus. Res."},{"issue":"8","key":"10.1016\/j.bsheal.2024.09.002_b0025","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.mayocp.2020.05.032","article-title":"Seasonality of coronavirus 229E, HKU1, NL63, and OC43 from 2014 to 2020","volume":"95","author":"Rucinski","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.bsheal.2024.09.002_b0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1574-6976.2006.00032.x","article-title":"Human coronavirus NL63, a new respiratory virus","volume":"30","author":"van der Hoek","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"issue":"11","key":"10.1016\/j.bsheal.2024.09.002_b0035","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bsheal.2024.09.002_b0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00705-021-05327-0","article-title":"Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal","volume":"167","author":"Wang","year":"2022","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.bsheal.2024.09.002_b0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"7819","key":"10.1016\/j.bsheal.2024.09.002_b0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bsheal.2024.09.002_b0055","doi-asserted-by":"crossref","first-page":"1184362","DOI":"10.3389\/fimmu.2023.1184362","article-title":"Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature","volume":"14","author":"Cantoni","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bsheal.2024.09.002_b0060","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2261566","article-title":"Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector","volume":"12","author":"Liang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.bsheal.2024.09.002_b0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12250-020-00237-y","article-title":"Monitoring neutralization property change of evolving hantaan and seoul viruses with a novel pseudovirus-based assay","volume":"36","author":"Ning","year":"2020","journal-title":"Virol. Sin."},{"issue":"1","key":"10.1016\/j.bsheal.2024.09.002_b0070","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1038\/srep42769","article-title":"Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system","volume":"7","author":"Nie","year":"2017","journal-title":"Sci. Rep."},{"issue":"7990","key":"10.1016\/j.bsheal.2024.09.002_b0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41586-023-06761-7","article-title":"TMPRSS2 is a functional receptor for human coronavirus HKU1","volume":"624","author":"Saunders","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bsheal.2024.09.002_b0080","doi-asserted-by":"crossref","first-page":"9122638","DOI":"10.3390\/cells9122638","article-title":"Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2","volume":"9","author":"Hatmal","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bsheal.2024.09.002_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104502","article-title":"From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses","volume":"85","author":"Kirtipal","year":"2020","journal-title":"Infect. Genet. Evol."},{"issue":"3","key":"10.1016\/j.bsheal.2024.09.002_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.bsheal.2024.09.002_b0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: Recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.bsheal.2024.09.002_b0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","article-title":"COVID-19, SARS and MERS: Are they closely related?","volume":"26","author":"Petrosillo","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bsheal.2024.09.002_b0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12985-015-0439-5","article-title":"MERS coronavirus: Diagnostics, epidemiology and transmission","volume":"12","author":"Mackay","year":"2015","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.bsheal.2024.09.002_b0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bsheal.2024.09.002_b0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41392-022-01087-8","article-title":"Animal models for COVID-19: Advances, gaps and perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bsheal.2024.09.002_b0120","first-page":"162","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.bsheal.2024.09.002_b0125","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay","volume":"15","author":"Nie","year":"2020","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.bsheal.2024.09.002_b0130","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/JCM.00533-08","article-title":"Human coronavirus NL63 and 229E seroconversion in children","volume":"46","author":"Dijkman","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.bsheal.2024.09.002_b0135","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/v13081579","article-title":"Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses","volume":"13","author":"Sampson","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.bsheal.2024.09.002_b0140","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41467-022-30658-0","article-title":"Antigenic structure of the human coronavirus OC43 spike reveals exposed and occluded neutralizing epitopes","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bsheal.2024.09.002_b0145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s10875-021-00997-6","article-title":"Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses","volume":"41","author":"Hicks","year":"2021","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bsheal.2024.09.002_b0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/vaccines11010058","article-title":"Analysis of antibody neutralisation activity against SARS-CoV-2 variants and seasonal human coronaviruses NL63, HKU1, and 229E induced by three different COVID-19 vaccine platforms","volume":"11","author":"Cantoni","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.bsheal.2024.09.002_b0155","doi-asserted-by":"crossref","unstructured":"E. Ito, A. Frische, P.T. Brooks, M. Gybel-Brask, S.G. S\u00e6kmose, B.A. Jensen, S. Mikkelsen, M.T. Bruun, L. Boding, C.P. Strandh, et al., Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay, PLoS One 17 (7) (2022) e0272298, https:\/\/doi.org\/10.1371\/journal.pone.0272298.","DOI":"10.1371\/journal.pone.0272298"},{"key":"10.1016\/j.bsheal.2024.09.002_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.853410","article-title":"Atypical antibody dynamics during human coronavirus HKU1 infections","volume":"13","author":"Sechan","year":"2022","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bsheal.2024.09.002_b0165","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00705-020-04914-x","article-title":"Circulation of human coronaviruses OC43 and 229E in C\u00f3rdoba, Argentina","volume":"166","author":"Ottogalli","year":"2021","journal-title":"Arch. Virol."},{"issue":"2022","key":"10.1016\/j.bsheal.2024.09.002_b0170","first-page":"1093","volume":"15","author":"C. Wen, L. Sun, M. Zhao, S. Duan, L. Wang, X. Cui, Clinical study of human coronavirus NL63, OC43, 229E, HKU1 infentions in hospitalized children from 2015 to 2020","year":"2015","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bsheal.2024.09.002_b0175","doi-asserted-by":"crossref","unstructured":"A.H.A. Lavell, J.J. Sikkens, A.W.D. Edridge, K. van der Straten, F. Sechan, M. Oomen, D.T.P. Buis, M. Schinkel, J.A. Burger, M. Poniman, et al., Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection, iScience 25(10) (2022) 105105, https:\/\/doi.org\/10.1016\/j.isci.2022.105105.","DOI":"10.1016\/j.isci.2022.105105"},{"issue":"2","key":"10.1016\/j.bsheal.2024.09.002_b0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1556\/030.2020.01059","article-title":"Human coronavirus OC43 and other respiratory viruses from acute respiratory infections of Egyptian children","volume":"67","author":"Naga","year":"2020","journal-title":"Acta Microbiol. Immunol. Hung."},{"issue":"11","key":"10.1016\/j.bsheal.2024.09.002_b0185","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00705-022-05541-4","article-title":"Genetic characteristics of human coronavirus HKU1 in mainland China during 2018","volume":"167","author":"Chen","year":"2022","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.bsheal.2024.09.002_b0190","first-page":"ofx052","article-title":"Human coronavirus-HKU1 infection among adults in cleveland, Ohio, open forum","volume":"4","author":"Kanwar","year":"2017","journal-title":"Infect. Dis."},{"key":"10.1016\/j.bsheal.2024.09.002_b0195","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijid.2021.02.085","article-title":"Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)","volume":"105","author":"Dugas","year":"2021","journal-title":"Int. J. Infect. Dis."}],"container-title":["Biosafety and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053624001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590053624001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T23:09:00Z","timestamp":1730588940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590053624001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2590053624001083"],"URL":"https:\/\/doi.org\/10.1016\/j.bsheal.2024.09.002","relation":{},"ISSN":["2590-0536"],"issn-type":[{"value":"2590-0536","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population","name":"articletitle","label":"Article Title"},{"value":"Biosafety and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bsheal.2024.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Chinese Medical Association Publishing House. Published by Elsevier BV.","name":"copyright","label":"Copyright"}]}}